COR Q1 2022 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q1 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$59.6B+13.5% YoY

Gross Profit

$1.9B3.2% margin

Operating Income

$714M1.2% margin

Net Income

$449M0.8% margin

EPS (Diluted)

$2.13

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$863M

Free Cash Flow

$784M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$57.6B

Total Liabilities

$57.0B

Stockholders' Equity

$242M

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59.6B	$52.5B	+13.5%
Gross Profit	$1.9B	$1.4B	+39.3%
Operating Income	$714M	$618M	+15.7%
Net Income	$449M	$375M	+19.8%

Revenue Segments

Pharmaceutical Distribution

$51.8B87%

International Healthcare Solutions

$6.6B11%

Animal Health

$1.2B2%

Geographic Segments

U.S. Healthcare Solutions

$53.0B89%

International Healthcare Solutions

$6.6B11%